Plasmacytoid predendritic cells (pDCs) are the main producers of type I interferon (IFN) in response to Toll-like receptor (TLR) stimulation. Phosphatidylinositol-3 kinase (PI3K) has been shown to be activated by TLR triggering in multiple cell types; however, its role in pDC function is not known. We show that PI3K is activated by TLR stimulation in primary human pDCs and demonstrate, using specifi c inhibitors, that PI3K is required for type I IFN production by pDCs, both at the transcriptional and protein levels. Importantly, PI3K was not involved in other proinfl ammatory responses of pDCs, including tumor necrosis factor ␣ and interleukin 6 production and DC differentiation. pDCs preferentially expressed the PI3K ␦ subunit, which was specifi cally involved in the control of type I IFN production. Although uptake and endosomal traffi cking of TLR ligands were not affected in the presence of PI3K inhibitors, there was a dramatic defect in the nuclear translocation of IFN regulatory factor (IRF) 7, whereas nuclear factor B activation was preserved. Thus, PI3K selectively controls type I IFN production by regulating IRF-7 nuclear translocation in human pDCs and could serve as a novel target to inhibit pathogenic type I IFN in autoimmune diseases.
BRIEF DEFINITIVE REPORT
Plasmacytoid pre-DCs (pDCs) are the main type I IFN producers in humans and mice ( 1 ) . They play a key role in innate antiviral immune responses but can also evolve into potent APCs and be important players in adaptive response ( 1, 2 ) . Activation of pDCs through Toll-like receptor (TLR) 7 and 9 can trigger both types of response, including large quantities of type I IFN production and/or DC diff erentiation ( 1 ) . Synthetic CpG-containing oligonucleotides of the types A and B (CpG-A and -B) selectively induce type I IFN production and DC diff erentiation, respectively ( 3 ), whereas some microbial stimuli such as influenza virus (Flu), HSV, or CpG-C can simultaneously induce both responses ( 1 ) . Two factors seem to be key for the induction of large quantities of type I IFN in pDCs: (a) the ability of the TLR ligand to bind its receptor in the early endosomal compartments ( 4, 5 ) and (b) the phosphorylation and nuclear translocation of the transcription factor IFN regulatory factor (IRF) 7 ( 6 ). This last step was shown to depend on IL-1 receptor -associated kinase 1 ( 7 ) and I B kinase (IKK) ␣ ( 8 ) in mouse pDCs. However, the molecular switch regulating type I IFN production versus DC diff erentiation in pDCs is not fully elucidated and could have important clinical implications, considering the link between a dysregulated TLR-induced IFN response and autoimmune diseases ( 9, 10 ) .
The phosphatidylinositol-3 kinase (PI3K) pathway is involved in a variety of biological processes, including cell survival and proliferation, B and T cell receptor signaling, and activation of G protein -coupled receptors, such as chemokine receptors ( 11 ) . PI3K contains regulatory subunits (p85 ␣ and ␤ ) and catalytic subunits (p110 ␣ , ␤ , ␥ , and ␦ ). PI3K ␥ and ␦ are preferentially expressed in cells of hemopoietic suggesting that PI3K may negatively regulate TLR-induced infl ammatory responses in APCs ( 13 ) . To address its role in human pDCs, purifi ed cells were stimulated with TLR9 (CpG-C, HSV) or TLR7 (Flu) ligands with or without the pharmacological inhibitors of PI3K, LY, and wortmannin. These TLR ligands induced high levels (20 -30 ng/ml) of IFN-␣ production by freshly sorted pDCs ( Fig. 2 A ) . This response was strongly inhibited by LY in a dose-dependent manner, with a maximal eff ect at 1.25 M LY for both TLR7 and 9 ligands ( Fig. 2 A ) . A 50% inhibition of IFN-␣ was still observed with LY concentrations as low as 0.08 M for TLR9 ( Fig. 2 A ) . Similarly, strong inhibition of IFN-␣ was observed in CpG-Astimulated pDCs (Fig. S1 , available at http://www.jem .org/cgi/content/full/jem.20070763/DC1). Importantly, no negative eff ect on pDC viability was observed at any of the concentrations used (Fig. S2) . Similar results were obtained with wortmannin (not depicted), another inhibitor targeting the PI3K pathway.
Specifi city of signaling inhibitors can be an issue, especially in cultures exceeding several hours. To exclude nonspecifi c eff ects caused by the potential toxicity of using PI3K inhibitors that could aff ect important functions of pDCs, we performed two types of experiments. First, we cultured pDCs for shorter periods of 2 and 5 h, and analyzed the ability of PI3K inhibitors to inhibit the IFN-␣ response at the transcriptional level. After 2 h, we detected signifi cant IFN-␣ , -␤ , and IFN-messenger RNA in the presence of CpG-C, which was almost completely inhibited by LY ( Fig. 2 B ) . The same magnitude of inhibition origin, whereas expression of PI3K ␣ and ␤ is ubiquitous. Accordingly, knockout mice for p110 ␣ and ␤ show embryonic lethality, whereas knockout mice for p110 ␥ and ␦ are viable and fertile and show altered phenotypes exclusively when their immune system is under acute stress ( 12 ) . The PI3K pathway has been shown to be activated by various TLR ligands and can function as a positive or negative regulator of TLR responses depending on the cell type and the TLR ligand used ( 13 ) . Inhibition of PI3K in mouse myeloid DCs and macrophages increased IL-12 production in response to TLR stimulation ( 13 ) , a result compatible with the in vivo observation of a skewed Th1 response in PI3K p85 ␣ Ϫ / Ϫ mice ( 14 ) and susceptibility to microbial-induced sepsis in mice through an increased production of innate cytokines ( 15 ) . In mouse CD4 + T cells, MyD88 was recently shown to activate PI3K and to enable CpG-mediated proliferation but not survival ( 16 ) . In mouse macrophages, however, CpG oligodeoxynucleotide (ODN) promoted survival through TLR9 and the PI3K pathway ( 17 ) . The function of PI3K in pDCs has not been evaluated. Cell type specifi city of PI3K, as well as discrepancies in the role of PI3K between cell lines and primary cells ( 11 ) , strengthened the need to study this pathway using human primary cells. In this report, we show that PI3K activation is an important early step in the signaling pathway leading to IRF-7 nuclear translocation and type I IFN production after TLR7 and 9 activation of human pDCs that diff erentially regulate the IRF-7 and NF-B signaling pathways.
RESULTS AND DISCUSSION TLR ligands induce PI3K-dependent Akt phosphorylation in primary human pDCs
To assess the activity of PI3K in primary human pDCs, we measured phosphorylated Akt (p-Akt), a downstream target of PI3K ( 11 ) . p-Akt was not detected at signifi cant levels in freshly sorted pDCs and was not induced by serum-containing medium ( Fig. 1 ) , as opposed to other cell-culture systems in which serum could induce PI3K activation ( 18 ) . However, p-Akt was up-regulated at both 20 and 90 min of culture in the presence of CpG-C or Flu ( Fig. 1, A and B ) . This increase was PI3K dependent because it could be blocked by the specifi c PI3K inhibitor LY294002 (LY) at both time points and for both TLR ligands ( Fig. 1, A and B ) . TLR9 signaling could lead to PI3K activation in diff erent cell types, such as CD4 + T cells ( 16 ) , mouse macrophages ( 17 ), or splenic DCs ( 19 ) . After TLR9 triggering, Akt phosphorylation was observed 30 min after CpG stimulation ( 16, 19 ) , which was comparable to our data on human pDCs. This rapid response, together with the ability of MyD88 to associate to the p85 subunit of PI3K ( 16 ) , supports a direct TLR-induced activation of PI3K rather than indirect activation through a TLR-induced autocrine loop.
Selective involvement of PI3K for type I IFN production by TLR-activated pDCs
The selective inhibition of PI3K in TLR2, 4, and 9-stimulated mouse DCs and macrophages enhanced IL-12 production, 
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Autocrine IFN-␣ signaling was shown to account for a portion of the induction of chemokines, such as CC chemokine ligand (CCL) 2 and IFN-␥ -inducible protein 10 (IP-10), in response to TLR9 activation ( 20 ) . Consistent with a strong inhibition of IFN-␣ production, PI3K inhibition induced a 70% reduction in the expression of CCL2 and IP-10 in CpG-activated pDCs (Fig. S3 , available at http://www.jem .org/cgi/content/full/jem.20070763/DC1).
In addition to large amounts of type I IFNs, TLR activation of pDCs can induce the production of proinfl ammatory cytokines such as IL-6 and TNF-␣ . In contrast to the strong inhibition of type I IFN, TNF-␣ and IL-6 production by pDCs in response to both TLR9 or 7 ligands was not signifi cantly aff ected by the addition of LY, even at high (5 M) concentrations of the inhibitor ( Fig. 3 , A and B ; and Fig. S1 ). This was confi rmed at the transcriptional level ( Fig. 3 C ) . Similarly, the pDCs diff erentiation into mature DCs, as assessed by surface expression of the co-stimulatory molecules CD80 and CD86, was not signifi cantly aff ected by PI3K inhibitors ( ). These data demonstrate that PI3K is selectively involved in the IFN-␣ pathway but not in the signaling events required for TNF-␣ or maturation induction. Moreover, they show that important functional pathways are conserved in pDCs despite PI3K inhibition, which, together with the conserved viability of pDCs, demonstrate that the observed eff ect on IFN-␣ was not caused by the overall toxicity of the inhibitor. Importantly, the PI3K inhibitor wortmannin was previously used as a means to inhibit autophagy in Flu-activated mouse pDCs without any eff ect in type I IFN production, suggesting major species-specifi c diff erences in the regulation of type I IFN production in human compared with mouse pDCs ( 21 ) . In contrast to our data, inhibition of IFN-␣ in human pDCs using specifi c inhibitors of TLRs ( 22 ), or after cross-linking of surface ILT7 ( 23 ) or BDCA2 ( 24 ) , induced a parallel decrease in TNF-␣ and IL-6 production, suggesting a diff erent molecular mechanism.
To further defi ne the function of the diff erent subunits of PI3K in human pDCs, we addressed (a) their expression profi le and (b) their respective contribution to regulate type I IFN in pDCs. First, we show that freshly purifi ed and activated pDCs preferentially expressed the p85 ␣ regulatory subunit and the p110 ␦ catalytic subunit ( Fig. 4 A ) . Second, the PI3K ␦ -specifi c inhibitor IC87114 ( 25 ) inhibited IFN-␣ production in a dose-dependent manner ( Fig. 4 B ) , whereas when we cultured pDCs in the presence of the PI3K ␥ -specifi c inhibitor AS604850, we did not observe any eff ect on IFN-␣ production unless used at high concentration ( > 20 M), where its specifi city for the ␥ subunit is lost ( 26 ) . These results demonstrate that the PI3K ␦ subunit is the essential subunit involved in the production of IFN-␣ by pDCs.
PI3K inhibition does not affect the uptake and endosomal location of CpG ODN CpG ODN requires both uptake and localization into appropriate endosomal compartments to signal through TLR9. It is possible that PI3K is required for one or both of these steps, was observed at 5 h of culture ( Fig. 2 B ) . Second, we attempted to reverse the inhibition of IFN-␣ production by washing out the inhibitor. After 5 h of culture, CpG-induced IFN-␣ production was inhibited in the presence of LY ( Fig. 2 C ) . Washing out the inhibitor after the fi rst 5 h enabled pDCs to recover their ability to produce large amounts of IFN-␣ during the subsequent 12 h ( Fig. 2 C ) . The supernatants were collected after 5 h, after which the cells were washed twice and restimulated with CpG-C or Flu for another 12 h. IFN-␣ production was evaluated by ELISA. The mean of three independent donors is shown. Data were analyzed using a two-tailed Student ' s t test. *, P < 0.05.
We and others have shown recently that the nature of the pDC response to TLR9 strongly depends on the intracellular compartment where the receptor/ligand interaction occurs ( 4, 5 ) . In human pDCs, the production of IFN-␣ is associated with the traffi cking of CpG in the early endosomal compartment, whereas maturation in APCs required accumulation of the CpG within the late endosomal compartment ( 5 ). We therefore investigated whether PI3K inhibition would interfere with the localization of the CpG in the early endosome compartment, a situation that is predicted to hamper IFN-␣ response. Transferrin receptor and Lamp-1 were used as markers of early and late endosomes, respectively. As previously described ( 5 ), in the absence of PI3K inhibition, fl uorescent CpG-C colocalized with transferrin receptor -as well as Lamp-containing endosomal compartments (Fig. S5 B) . This pattern of distribution was not aff ected by PI3K inhibitors, indicating that PI3K does not interfere with the intracellular traffi cking of CpG in primary pDCs (Fig. S5, B and C) . Importantly, this shows that although we cannot exclude that blocking PI3K may have some eff ect on endosomal traffi cking, it did not prevent the localization of the CpG in the early endosome that is essential for triggering IFN-␣ at time points where inhibition of IFN-␣ was almost complete by gene expression analysis ( Fig. 2 B ) . Furthermore, the concentration of LY was similar to the one used to demonstrate inhibition of IFN-␣ at a similar time of stimulation ( Fig. 2 B ) . These data show that PI3K does not interfere with the uptake and distribution of the TLR ligands and suggest that it could be an important player in the signaling pathway downstream of TLR7 or 9 activation. rather than for signal transduction downstream of TLR9. To test the role of PI3K in uptake, we used fl uorescent CpG ODN and demonstrated that inhibiting PI3K with LY or wortmannin did not have any eff ect on CpG uptake, as measured by fl ow cytometry (Fig. S5 A, available at http://www.jem.org/cgi/ content/full/jem.20070763/DC1). PI3K was described to be important for phagocytosis and endocytosis in various cellular models ( 27 ) , partly by contributing to phagosome formation and maturation ( 27, 28 ) . In addition, it was previously shown that blocking PI3K resulted in a complete blockade of CpG ODN uptake in mouse myeloid DCs and TLR9-transfected HEK 293 cells ( 29 ) . Diff erences in the cell type used could account for this discrepancy. 
to be key for the high magnitude of IFN-␣ response upon TLR7/9 ligation in human pDCs ( 30 ) . We thus investigated whether PI3K alters this pathway by looking at both transcriptional up-regulation of IRF-7 and its ability to migrate to the nucleus upon activation. First, we observed that freshly
PI3K is required for IRF-7 nuclear translocation but not NF-B phosphorylation in TLR-activated pDCs
In mouse pDCs, IFN-␣ production depends on the activation and translocation of IRF-7 to the nucleus ( 6 ) . Moreover the strong up-regulation of IRF-7 messenger was suggested type I IFN. Which is the specifi c target of PI3K, and whether the PI3K pathway regulates the function and/or recruitment of TNF receptor -associated factor 6, osteopontin, or IKK-␣ , will be important questions to be addressed in future studies.
The dissection of the molecular mechanisms controlling the innate functions of pDCs could uncover new ways to manipulate these cells in pathological conditions, such as autoimmune or infectious diseases. There is increasing evidence for a role of IFN-␣ in the development of autoimmunity, and pDCs, through their production of high levels of type I IFN, were implicated in the pathophysiology of various autoimmune diseases, such as systemic lupus erythematosus, psoriasis, or Sj ö gren ' s disease ( 9, 10 ) . PI3K inhibitors, in particular those specifi cally targeting the ␦ subunit as nonspecifi c PI3K inhibitors could generate toxicity, off er a unique way to selectively block type I IFN production while preserving NF-B -dependent responses, which could have important proinfl ammatory or regulatory eff ects through modulation of T cell responses.
MATERIALS AND METHODS

Reagents.
Oligonucleotides CpG-C C274 and CpG-A D19 were prepared as previously described ( 3 ) . UV-inactivated HSV-1 was a gift from R. Pyles (University of Texas Medical Branch, Galveston, TX). Heat-inactivated infl uenza virus (H1N1, strain A/PR/8/34) was obtained from the American Type Culture Collection. PI3K inhibitors (LY and wortmannin), and the NF-B inhibitor (IKK-2 IV) were purchased from Calbiochem. PI3K ␥ inhibitor (AS 604850) was purchased from Echelon. PI3K ␦ inhibitor (IC 87114) was synthesized as previously described (patent application US 20050261317 A1).
Human IFN-␣ , IL-6, and TNF-␣ ELISA sets were purchased from PBL Biomedical Laboratories; anti-CD123, anti-CD80, anti-CD86, anti-CD71, and anti-CD107a were purchased from BD Biosciences; and anti -BDCA-2 was purchased from Miltenyi Biotec.
Isolation and stimulation of purifi ed human cell subsets. Buff y coats were obtained from the Stanford Blood Center and cells were used under internal Institutional Review Board -approved protocols, or they were obtained from adult healthy donors at the Saint-Antoine Crozatier Blood Bank, where all donors signed informed consent to allow the use of their blood for research purposes. This study was approved by the Institut Curie Internal Review Board and by the French National Blood Agency. pDCs were isolated either by using positive selection using BDCA-4 -conjugated beads or by using negative depletion (Miltenyi Biotec), as previously described ( 35 ) . pDCs were 94 -99% BDCA2 + CD123 + , as determined by fl ow cytometry.
Detection of p-AKT and NF-B by fl ow cytometry. Negatively purifi ed pDCs were stimulated with CpG-C, and cells were immediately fi xed with 4% paraformaldehyde for 15 min at 37 ° C. Cells were then washed, permeabilized with PermBuff er III (BD Biosciences) for 30 min on ice, and stained with either Alexa Fluor 647 anti -human NF-B p65 (pS529) or with Alexa Fluor 647 anti -human AKT (pS473; BD Biosciences) for 30 min and analyzed by fl ow cytometry.
NF-B transcription factor binding activity. Negatively purifi ed pDCs were stimulated and nuclear extracts were prepared. NF-B activities were measured using TransAM NF-B kits (Active Motif) according to the manufacturer ' s instructions.
Real-time quantitative PCR (TaqMan) analysis. PCR reactions were performed as described previously ( 3 ) . In brief, threshold cycle (CT) values for each gene were normalized to the housekeeping gene ubiquitin or ␤ -actin using the formula Eq. 1.8 (HSKGENE) (100,000), where HSK is the mean CT of triplicate housekeeping gene runs, GENE is the mean CT of duplicate sorted pDCs constitutively expressed IRF-7 messenger RNA, and that its level was increased 2 and 5 h after CpG stimulation ( Fig. 5 A ) . This transcriptional up-regulation of IRF-7 was not aff ected in the presence of PI3K inhibitor ( Fig. 5 A ) . We then studied the nuclear translocation of IRF-7. Using confocal microscopy, we found that IRF-7 protein was expressed in the cytoplasm of unstimulated pDCs and did not colocalize with the DAPI nuclear staining ( Fig. 5 B ) . MHC class II surface staining was used to visualize the pDCs. After stimulation with CpG, the majority of IRF-7 translocated to the nucleus, as assessed by the colocalization of the IRF-7 (red) and DAPI (blue) stainings, as well as the reduction of detectable IRF-7 staining in the cytoplasmic compartment ( Fig. 5 B ) . This process was dramatically decreased in the presence of a PI3K inhibitor, with the majority of the IRF-7 staining remaining in the cytoplasm ( Fig. 5 B ) . The total number of cells showing nuclear staining of IRF-7 returned to baseline levels in the presence of LY ( Fig. 5 C ) . Similar results were obtained with both IFN-inducing classes of CpG, A and C, as well as with HSV (not depicted).
As shown in Figs. 2 and 3 , PI3K appears to be essential for IFN-␣ response but not for other infl ammatory cytokines and DC diff erentiation, two responses that were shown in the mouse to be mostly NF-B dependent ( 31 ) . We show that in parallel to IRF-7 activation, CpG-C also induced phosphorylation of NF-B, as assessed by fl ow cytometry ( Fig. 5 D ) . Interestingly, although the NF-B phosphorylation was inhibited using a specifi c NF-B inhibitor, we did not observe any signifi cant eff ect of the PI3K inhibitor LY ( Fig. 5 D ) . To confi rm that the NF-B pathway was not aff ected after PI3K inhibition, we analyzed pDC nuclear extracts for the binding activity of NF-B p50 and p65 subunits. No diff erence was detected in the absence or presence of LY ( Fig. 5 E ) . These data suggest an absence of cross talk between the PI3K and NF-B pathways in human pDCs . This may not be the case in other cell types, as PI3K could favor NF-B activity in cell lines ( 32 ) .
Our results provide a molecular link between PI3K activity and the regulation of type I IFN production by pDCs, and identify PI3K as an essential component of the pathway leading to IFN production in pDCs. IRF-7 was shown to be essential for IFN-␣ production by pDCs in mice ( 6 ) and to form a complex with MyD88 and TNF receptor -associated factor 6 for the induction of type I IFN ( 33 ) . However, the factors regulating its phosphorylation and subsequent translocation to the nucleus are not completely elucidated, and no data are available in human pDCs. Recently, two independent studies showed that intracellular osteopontin ( 34 ) , as well as IKK-␣ ( 8 ), were required for IRF-7 nuclear translocation and type I IFN production in mouse pDCs. Our data show that PI3K is a key component of the signal transduction pathway that controls IRF-7 nuclear translocation and subsequent type I IFN production by human pDCs. In addition, a previous report has suggested that PI3K could act as a negative regulator during the initial phase of innate response to microbial pathogens ( 13 ) . On the contrary, our results suggest that PI3K is essential for pDCs to respond properly to viruses by favoring early production of
